Literature DB >> 18554308

Abnormal thyroid function in older men with or at risk for HIV infection.

M Wiener1, Y Lo, R S Klein.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the prevalence of and factors associated with abnormal thyroid function in older men with or at risk for HIV infection.
METHODS: A cross-sectional analysis of 636 men > or =49 years old was carried out using data obtained from interviews, from measurements of body mass index (BMI), HIV-1 serology and viral load, CD4 cell count, hepatitis C virus (HCV) assays, thyroid-stimulating hormone (TSH) and free thyroid hormone levels.
RESULTS: Participants were 54% black, 57% overweight/obese, 57% HIV seropositive, and 72% HCV seropositive; 38% reported recent cocaine or heroin use. Decreased TSH was found in 56 men (8.8%) and raised TSH in 23 men (3.6%). Only three men had abnormal free thyroxine levels.
CONCLUSIONS: Abnormal TSH levels were noted in 12.4% of older men with or at risk for HIV infection, but nearly all reflected subclinical hyperthyroidism or subclinical hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554308      PMCID: PMC2574588          DOI: 10.1111/j.1468-1293.2008.00601.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  17 in total

1.  Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy.

Authors:  Leonardo Calza; Roberto Manfredi; Francesco Chiodo
Journal:  J Acquir Immune Defic Syndr       Date:  2002-11-01       Impact factor: 3.731

2.  Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system.

Authors:  Julio Collazos; Sofía Ibarra; José Mayo
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

3.  The Colorado thyroid disease prevalence study.

Authors:  G J Canaris; N R Manowitz; G Mayor; E C Ridgway
Journal:  Arch Intern Med       Date:  2000-02-28

4.  Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS)

Authors:  J S LoPresti; J C Fried; C A Spencer; J T Nicoloff
Journal:  Ann Intern Med       Date:  1989-06-15       Impact factor: 25.391

5.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

6.  Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection.

Authors:  M Lambert; F Zech; P De Nayer; J Jamez; B Vandercam
Journal:  Am J Med       Date:  1990-12       Impact factor: 4.965

Review 7.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

Authors:  Martin I Surks; Eduardo Ortiz; Gilbert H Daniels; Clark T Sawin; Nananda F Col; Rhoda H Cobin; Jayne A Franklyn; Jerome M Hershman; Kenneth D Burman; Margo A Denke; Colum Gorman; Richard S Cooper; Neil J Weissman
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

Review 8.  Thyroid function abnormalities in HIV-infected patients.

Authors:  Christopher J Hoffmann; Todd T Brown
Journal:  Clin Infect Dis       Date:  2007-06-28       Impact factor: 9.079

9.  Combination antiretroviral therapy and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

10.  Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening.

Authors:  Sonia Beltran; François-Xavier Lescure; Rachel Desailloud; Youcef Douadi; Amar Smail; Isabelle El Esper; Sylvie Arlot; Jean-Luc Schmit
Journal:  Clin Infect Dis       Date:  2003-07-28       Impact factor: 9.079

View more
  4 in total

1.  Physiological and psychosocial factors that predict HIV-related fatigue.

Authors:  Julie Barroso; Bradley G Hammill; Jane Leserman; Naima Salahuddin; James L Harmon; Brian Wells Pence
Journal:  AIDS Behav       Date:  2010-12

2.  Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation.

Authors:  Dianne Langford; David Baron; Javed Joy; Luis Del Valle; Jonathon Shack
Journal:  Psychoneuroendocrinology       Date:  2010-11-05       Impact factor: 4.905

Review 3.  Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.

Authors:  Nazik Elmalaika Os Husain; Mohamed H Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2014-12-17

4.  Low prevalence of symptomatic thyroid diseases and thyroid cancers in HIV-infected patients.

Authors:  Martina Properzi; Tommaso Della Giustina; Sara Mentasti; Francesco Castelli; Annacarla Chiesa; Natalia Gregori; Eugenia Quiros-Roldan
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.